FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
PloS one2012; 7(11); e48978; doi: 10.1371/journal.pone.0048978

Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease.

Abstract: The contribution of inflammation to the pathogenesis of tendinopathy and high prevalence of re-injury is not well established, although recent evidence suggests involvement of prostaglandins. We investigated the roles of prostaglandins and inflammation-resolving mediators in naturally occurring equine tendon injury with disease stage and age. Levels of prostaglandins E(2) (PGE(2)), F(2α) (PGF(2α)), lipoxin A(4) (LXA(4)) and its receptor FPR2/ALX were analysed in extracts of normal, sub-acute and chronic injured tendons. To assess whether potential changes were associated with altered PGE(2) metabolism, microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin dehydrogenase (PGDH), COX-2 and EP(4) receptor expression were investigated. The ability of tendons to resolve inflammation was determined by assessing FPR2/ALX expression in natural injury and IL-1β stimulated tendon explants.Alterations in the profile of lipid mediators during sub-acute injury included low PGE(2) and elevated LXA(4) levels compared to normal and chronic injuries. In contrast, PGF(2α) levels remained unchanged and were three-fold lower than PGE(2). The synthetic capacity of PGE(2) as measured by the ratio of mPGES-1:PGDH was elevated in sub-acute injury, suggesting aberrations in tendon prostaglandin metabolism, whilst COX-2 and EP(4) receptor were unchanged. Paradoxically low tendon PGE(2) levels in early injury may be attributed to increased local clearance via PGDH or the class switching of lipid mediators from the prostaglandin to the lipoxin axis. PGE(2) is therefore implicated in the development of tendon inflammation and its ensuing resolution. Whilst there was no relationship between age and tendon LXA(4) levels, there was an age-associated decline in FPR2/ALX receptor expression with concurrent increased PGE(2) levels in injury. Furthermore, uninjured tendon explants from younger (<10 years) but not older horses (≥10 years) treated with IL-1β responded by increasing FPR2/ALX suggesting aged individuals exhibit a reduced capacity to resolve inflammation via FPR2/ALX, which may present a potential mechanism for development of chronic tendinopathy and re-injury.
Get Full Text
Publication Date: 2012-11-14 PubMed ID: 23155437PubMed Central: PMC3498370DOI: 10.1371/journal.pone.0048978Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigates the role of inflammation and specific chemicals, known as arachidonic acid metabolites, in the development and progression of tendon disease. The study focuses on horses, but the findings may also apply to other species.

Study Methods and Material

  • The study analyzed the levels of four specific chemicals (prostaglandins E(2) and F(2α), lipoxin A(4) and its receptor FPR2/ALX) in extracts of healthy and diseased tendons in horses that had naturally occurring tendon injury.
  • They assessed both early stage, or sub-acute, and chronic forms of tendon injury.
  • They also investigated the expression of additional compounds related to inflammation and tendon metabolism, including microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin dehydrogenase (PGDH), COX-2 and the EP(4) receptor.
  • They used tendon explants, or tissue extracted from the horses, to evaluate how tendons respond to an inflammation stimulus.

Key Findings

  • The study found varied levels of the studied chemicals between healthy and injured tendons, and depending on the stage of injury.
  • Injured tendons in the sub-acute stage had low levels of PGE(2) and elevated levels of LXA(4), unlike healthy and chronically injured tendons.
  • The study suggests that an imbalance in the synthesis and clearance of PGE(2) could contribute to tendon inflammation and its resolution.
  • Interestingly, age played a role in the levels of another chemical, FPR2/ALX. Uninjured tendons from younger horses (less than 10 years old) increased their expression of this receptor in response to an inflammatory stimulus, unlike tendons from older horses. This suggests that older individuals may have a reduced capacity to resolve inflammation via FPR2/ALX, which could contribute to the development of chronic tendon disease and reinjury.

Implications for Veterinary Medicine

  • These findings contribute to a better understanding of the biological processes involved in tendon disease and could help veterinarians develop better treatment approaches.
  • By uncovering the role of inflammation and specific chemicals in tendon disease, the study may pave the way for the development of targeted therapies.
  • Given the involvement of age in disease progression, the research could also lead to specialized treatment plans for horses of different ages.

Cite This Article

APA
Dakin SG, Dudhia J, Werling NJ, Werling D, Abayasekara DR, Smith RK. (2012). Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. PLoS One, 7(11), e48978. https://doi.org/10.1371/journal.pone.0048978

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 7
Issue: 11
Pages: e48978
PII: e48978

Researcher Affiliations

Dakin, Stephanie Georgina
  • Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, Hatfield, United Kingdom. sdakin@rvc.ac.uk
Dudhia, Jayesh
    Werling, Natalie Jayne
      Werling, Dirk
        Abayasekara, Dilkush Robert Ephrem
          Smith, Roger Kenneth Whealands

            MeSH Terms

            • Aging / metabolism
            • Animals
            • Dinoprost / metabolism
            • Dinoprostone / metabolism
            • Horses
            • Inflammation / metabolism
            • Lipoxins / metabolism
            • Receptors, Formyl Peptide / metabolism
            • Receptors, Lipoxin / metabolism
            • Tendinopathy / metabolism
            • Tendon Injuries / metabolism
            • Tendons / metabolism

            Grant Funding

            • BB/F018258/1 / Biotechnology and Biological Sciences Research Council

            Conflict of Interest Statement

            The authors declare the study was in part funded by Ceva (France). There are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

            References

            This article includes 59 references
            1. Kujala UM, Sarna S, Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes.. Clin J Sport Med 2005 May;15(3):133-5.
              pubmed: 15867554doi: 10.1097/01.jsm.0000165347.55638.23google scholar: lookup
            2. Avella CS, Ely ER, Verheyen KL, Price JS, Wood JL, Smith RK. Ultrasonographic assessment of the superficial digital flexor tendons of National Hunt racehorses in training over two racing seasons.. Equine Vet J 2009 May;41(5):449-54.
              pubmed: 19642404doi: 10.2746/042516409x391042google scholar: lookup
            3. Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature.. Med Sci Sports Exerc 1998 Aug;30(8):1183-90.
              pubmed: 9710855doi: 10.1097/00005768-199808000-00001google scholar: lookup
            4. Birch HL, Bailey AJ, Goodship AE. Macroscopic 'degeneration' of equine superficial digital flexor tendon is accompanied by a change in extracellular matrix composition.. Equine Vet J 1998 Nov;30(6):534-9.
              pubmed: 9844973doi: 10.1111/j.2042-3306.1998.tb04530.xgoogle scholar: lookup
            5. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000).. Equine Vet J 2004 Jul;36(5):415-9.
              pubmed: 15253082doi: 10.2746/0425164044868422google scholar: lookup
            6. Crevier-Denoix N, Collobert C, Pourcelot P, Denoix JM, Sanaa M, Geiger D, Bernard N, Ribot X, Bortolussi C, Bousseau B. Mechanical properties of pathological equine superficial digital flexor tendons.. Equine Vet J Suppl 1997 May;(23):23-6.
              pubmed: 9354282doi: 10.1111/j.2042-3306.1997.tb05046.xgoogle scholar: lookup
            7. Alfredson H, Lorentzon R. Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?. Curr Drug Targets 2002 Feb;3(1):43-54.
              pubmed: 11899264doi: 10.2174/1389450023348028google scholar: lookup
            8. Kannus P, Józsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients.. J Bone Joint Surg Am 1991 Dec;73(10):1507-25.
              pubmed: 1748700
            9. Dudhia J, Scott CM, Draper ER, Heinegård D, Pitsillides AA, Smith RK. Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity.. Aging Cell 2007 Aug;6(4):547-56.
              pubmed: 17578513doi: 10.1111/j.1474-9726.2007.00307.xgoogle scholar: lookup
            10. Strocchi R, De Pasquale V, Guizzardi S, Govoni P, Facchini A, Raspanti M, Girolami M, Giannini S. Human Achilles tendon: morphological and morphometric variations as a function of age.. Foot Ankle 1991 Oct;12(2):100-4.
              pubmed: 1773989doi: 10.1177/107110079101200207google scholar: lookup
            11. Wilson AM, McGuigan MP, Su A, van Den Bogert AJ. Horses damp the spring in their step.. Nature 2001 Dec 20-27;414(6866):895-9.
              pubmed: 11780059doi: 10.1038/414895agoogle scholar: lookup
            12. Ker RF, Wang XT, Pike AV. Fatigue quality of mammalian tendons.. J Exp Biol 2000 Apr;203(Pt 8):1317-27.
              pubmed: 10729280doi: 10.1242/jeb.203.8.1317google scholar: lookup
            13. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse.. Equine Vet J 2000 Sep;32(5):369-78.
              pubmed: 11037257doi: 10.2746/042516400777591138google scholar: lookup
            14. Stephens PR, Nunamaker DM, Butterweck DM. Application of a Hall-effect transducer for measurement of tendon strains in horses.. Am J Vet Res 1989 Jul;50(7):1089-95.
              pubmed: 2774333
            15. Riemersma DJ, Schamhardt HC. In vitro mechanical properties of equine tendons in relation to cross-sectional area and collagen content.. Res Vet Sci 1985 Nov;39(3):263-70.
              pubmed: 4081329
            16. Dakin SG, Werling D, Hibbert A, Abayasekara DR, Young NJ, Smith RK, Dudhia J. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair.. PLoS One 2012;7(2):e32333.
              pmc: PMC3284560pubmed: 22384219doi: 10.1371/journal.pone.0032333google scholar: lookup
            17. Kasashima Y, Takahashi T, Smith RK, Goodship AE, Kuwano A, Ueno T, Hirano S. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999.. Equine Vet J 2004 May;36(4):346-50.
              pubmed: 15163043doi: 10.2746/0425164044890580google scholar: lookup
            18. Möller A, Astron M, Westlin N. Increasing incidence of Achilles tendon rupture.. Acta Orthop Scand 1996 Oct;67(5):479-81.
              pubmed: 8948254doi: 10.3109/17453679608996672google scholar: lookup
            19. Maffulli N, Waterston SW, Squair J, Reaper J, Douglas AS. Changing incidence of Achilles tendon rupture in Scotland: a 15-year study.. Clin J Sport Med 1999 Jul;9(3):157-60.
              pubmed: 10512344doi: 10.1097/00042752-199907000-00007google scholar: lookup
            20. Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells.. J Orthop Res 2003 Mar;21(2):256-64.
              pubmed: 12568957doi: 10.1016/S0736-0266(02)00141-9google scholar: lookup
            21. Khan MH, Li Z, Wang JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration.. Clin J Sport Med 2005 Jan;15(1):27-33.
              pubmed: 15654188doi: 10.1097/00042752-200501000-00006google scholar: lookup
            22. Yang G, Im HJ, Wang JH. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts.. Gene 2005 Dec 19;363:166-72.
              pmc: PMC2901527pubmed: 16226404doi: 10.1016/j.gene.2005.08.006google scholar: lookup
            23. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.. J Clin Invest 2001 Jul;108(1):15-23.
              pmc: PMC209346pubmed: 11435451doi: 10.1172/JCI13416google scholar: lookup
            24. Langberg H, Skovgaard D, Karamouzis M, Bülow J, Kjaer M. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans.. J Physiol 1999 Mar 15;515 ( Pt 3)(Pt 3):919-27.
              pmc: PMC2269174pubmed: 10066916doi: 10.1111/j.1469-7793.1999.919ab.xgoogle scholar: lookup
            25. Zhang J, Wang JH. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes.. J Orthop Res 2010 Feb;28(2):198-203.
              pubmed: 19688869doi: 10.1002/jor.20962google scholar: lookup
            26. Almekinders LC, Banes AJ, Ballenger CA. Effects of repetitive motion on human fibroblasts.. Med Sci Sports Exerc 1993 May;25(5):603-7.
              pubmed: 8388071
            27. Almekinders LC, Baynes AJ, Bracey LW. An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts.. Am J Sports Med 1995 Jan-Feb;23(1):119-23.
              pubmed: 7726341doi: 10.1177/036354659502300120google scholar: lookup
            28. Wang JH, Li Z, Yang G, Khan M. Repetitively stretched tendon fibroblasts produce inflammatory mediators.. Clin Orthop Relat Res 2004 May;(422):243-50.
              pubmed: 15187863doi: 10.1097/01.blo.0000126337.65685.e4google scholar: lookup
            29. Ruwanpura SM, Noguchi K, Ishikawa I. Prostaglandin E2 regulates interleukin-1beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts.. J Dent Res 2004 Mar;83(3):260-5.
              pubmed: 14981131doi: 10.1177/154405910408300315google scholar: lookup
            30. Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, Pillinger MH, Abramson SB. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.. J Immunol 2008 Oct 1;181(7):5082-8.
              pubmed: 18802112doi: 10.4049/jimmunol.181.7.5082google scholar: lookup
            31. Thampatty BP, Li H, Im HJ, Wang JH. EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment.. Gene 2007 Jan 15;386(1-2):154-61.
              pmc: PMC1839868pubmed: 17046175doi: 10.1016/j.gene.2006.08.027google scholar: lookup
            32. Hahn EL, Gamelli RL. Prostaglandin E2 synthesis and metabolism in burn injury and trauma.. J Trauma 2000 Dec;49(6):1147-54.
              pubmed: 11130507doi: 10.1097/00005373-200012000-00033google scholar: lookup
            33. Serhan CN, Takano T, Chiang N, Gronert K, Clish CB. Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability.. Am J Respir Crit Care Med 2000 Feb;161(2 Pt 2):S95-S101.
              pubmed: 10673235doi: 10.1164/ajrccm.161.supplement_1.ltta-19google scholar: lookup
            34. Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.. Pharmacol Rev 2006 Sep;58(3):463-87.
              pubmed: 16968948doi: 10.1124/pr.58.3.4google scholar: lookup
            35. Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes.. Proc Natl Acad Sci U S A 1984 Sep;81(17):5335-9.
              pmc: PMC391698pubmed: 6089195doi: 10.1073/pnas.81.17.5335google scholar: lookup
            36. Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.. J Exp Med 1997 May 5;185(9):1693-704.
              pmc: PMC2196289pubmed: 9151906doi: 10.1084/jem.185.9.1693google scholar: lookup
            37. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence.. Ann N Y Acad Sci 2000 Jun;908:244-54.
              pubmed: 10911963doi: 10.1111/j.1749-6632.2000.tb06651.xgoogle scholar: lookup
            38. Järvinen TA, Kannus P, Maffulli N, Khan KM. Achilles tendon disorders: etiology and epidemiology.. Foot Ankle Clin 2005 Jun;10(2):255-66.
              pubmed: 15922917doi: 10.1016/j.fcl.2005.01.013google scholar: lookup
            39. Sayasith K, Bouchard N, Doré M, Sirois J. Cloning of equine prostaglandin dehydrogenase and its gonadotropin-dependent regulation in theca and mural granulosa cells of equine preovulatory follicles during the ovulatory process.. Reproduction 2007 Feb;133(2):455-66.
              pubmed: 17307913doi: 10.1530/REP-06-0210google scholar: lookup
            40. Jones GC, Corps AN, Pennington CJ, Clark IM, Edwards DR, Bradley MM, Hazleman BL, Riley GP. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon.. Arthritis Rheum 2006 Mar;54(3):832-42.
              pubmed: 16508964doi: 10.1002/art.21672google scholar: lookup
            41. Graham S, Gamie Z, Polyzois I, Narvani AA, Tzafetta K, Tsiridis E, Helioti M, Mantalaris A, Tsiridis E. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.. Expert Opin Investig Drugs 2009 Jun;18(6):746-66.
              pubmed: 19426119doi: 10.1517/13543780902893051google scholar: lookup
            42. Dunn M. The role of arachidonic acid metabolites in renal homeostasis. Non-steroidal anti-inflammatory drugs renal function and biochemical, histological and clinical effects and drug interactions.. Drugs 1987;33 Suppl 1:56-66.
              pubmed: 3109872doi: 10.2165/00003495-198700331-00009google scholar: lookup
            43. Stanley RL, Fleck RA, Becker DL, Goodship AE, Ralphs JR, Patterson-Kane JC. Gap junction protein expression and cellularity: comparison of immature and adult equine digital tendons.. J Anat 2007 Sep;211(3):325-34.
              pmc: PMC2375813pubmed: 17848160doi: 10.1111/j.1469-7580.2007.00781.xgoogle scholar: lookup
            44. Young NJ, Becker DL, Fleck RA, Goodship AE, Patterson-Kane JC. Maturational alterations in gap junction expression and associated collagen synthesis in response to tendon function.. Matrix Biol 2009 Jul;28(6):311-23.
              pubmed: 19481603doi: 10.1016/j.matbio.2009.05.002google scholar: lookup
            45. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function.. Aging Cell 2004 Aug;3(4):161-7.
              pubmed: 15268749doi: 10.1111/j.1474-9728.2004.00102.xgoogle scholar: lookup
            46. Fincham N, Camp R. Novel prostaglandin dehydrogenase in rat skin.. Biochem J 1983 Apr 15;212(1):129-34.
              pmc: PMC1152019pubmed: 6575778doi: 10.1042/bj2120129google scholar: lookup
            47. Blackwell GJ, Flower RJ, Vane JR. Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors.. Br J Pharmacol 1975 Oct;55(2):233-8.
              pmc: PMC1666836pubmed: 1201382doi: 10.1111/j.1476-5381.1975.tb07633.xgoogle scholar: lookup
            48. Strömberg B. Morphologic, thermographic and 133Xe clearance studies on normal and diseased superficial digital flexor tendons in race horses.. Equine Vet J 1973 Oct;5(4):156-61.
              pubmed: 4766689doi: 10.1111/j.2042-3306.1973.tb03217.xgoogle scholar: lookup
            49. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution.. Nat Immunol 2001 Jul;2(7):612-9.
              pubmed: 11429545doi: 10.1038/89759google scholar: lookup
            50. Knudsen PJ, Dinarello CA, Strom TB. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate.. J Immunol 1986 Nov 15;137(10):3189-94.
              pubmed: 3021848
            51. Serhan CN, Chiang N. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.. ScientificWorldJournal 2002 Jan 22;2:169-204.
              pmc: PMC6009744pubmed: 12806051doi: 10.1100/tsw.2002.81google scholar: lookup
            52. Desai A, Grolleau-Julius A, Yung R. Leukocyte function in the aging immune system.. J Leukoc Biol 2010 Jun;87(6):1001-9.
              pmc: PMC4057658pubmed: 20200405doi: 10.1189/jlb.0809542google scholar: lookup
            53. Gosain A, DiPietro LA. Aging and wound healing.. World J Surg 2004 Mar;28(3):321-6.
              pubmed: 14961191doi: 10.1007/s00268-003-7397-6google scholar: lookup
            54. Almekinders LC, Deol G. The effects of aging, antiinflammatory drugs, and ultrasound on the in vitro response of tendon tissue.. Am J Sports Med 1999 Jul-Aug;27(4):417-21.
              pubmed: 10424209doi: 10.1177/03635465990270040301google scholar: lookup
            55. Zhang J, Wang JH. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes.. J Orthop Res 2010 Feb;28(2):198-203.
              pubmed: 19688869doi: 10.1002/jor.20962google scholar: lookup
            56. Cheng Z, Robinson RS, Pushpakumara PG, Mansbridge RJ, Wathes DC. Effect of dietary polyunsaturated fatty acids on uterine prostaglandin synthesis in the cow.. J Endocrinol 2001 Dec;171(3):463-73.
              pubmed: 11739012doi: 10.1677/joe.0.1710463google scholar: lookup
            57. Young NJ, Thomas CJ, Collins ME, Brownlie J. Real-time RT-PCR detection of Bovine Viral Diarrhoea virus in whole blood using an external RNA reference.. J Virol Methods 2006 Dec;138(1-2):218-22.
              pmc: PMC7112878pubmed: 17030066doi: 10.1016/j.jviromet.2006.08.008google scholar: lookup
            58. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR.. Nucleic Acids Res 2001 May 1;29(9):e45.
              pmc: PMC55695pubmed: 11328886doi: 10.1093/nar/29.9.e45google scholar: lookup
            59. Romijn HJ, van Uum JF, Breedijk I, Emmering J, Radu I, Pool CW. Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy.. J Histochem Cytochem 1999 Feb;47(2):229-36.
              pubmed: 9889258doi: 10.1177/002215549904700211google scholar: lookup

            Citations

            This article has been cited 29 times.
            Subscribe to our newsletter
            Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.